Viral vectors in gene therapy: Where do we stand in 2023?
K Lundstrom - Viruses, 2023 - mdpi.com
Viral vectors have been used for a broad spectrum of gene therapy for both acute and
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …
Viral vector-based gene therapy
X Li, Y Le, Z Zhang, X Nian, B Liu, X Yang - International Journal of …, 2023 - mdpi.com
Gene therapy is a technique involving the modification of an individual's genes for treating a
particular disease. The key to effective gene therapy is an efficient carrier delivery system …
particular disease. The key to effective gene therapy is an efficient carrier delivery system …
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
Therapeutic strategies based on modulation of microRNA (miRNA) activity hold great
promise due to the ability of these small RNAs to potently influence cellular behavior. In this …
promise due to the ability of these small RNAs to potently influence cellular behavior. In this …
Viral vectors in gene therapy
K Lundstrom - Diseases, 2018 - mdpi.com
Applications of viral vectors have found an encouraging new beginning in gene therapy in
recent years. Significant improvements in vector engineering, delivery, and safety have …
recent years. Significant improvements in vector engineering, delivery, and safety have …
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models
F Maione, F Molla, C Meda, R Latini… - The Journal of …, 2009 - Am Soc Clin Investig
Tumor growth and progression rely upon angiogenesis, which is regulated by pro-and
antiangiogenic factors, including members of the semaphorin family. By analyzing 3 different …
antiangiogenic factors, including members of the semaphorin family. By analyzing 3 different …
Small silencing RNAs: state-of-the-art
D Grimm - Advanced drug delivery reviews, 2009 - Elsevier
Over just a single decade, we have witnessed the rapid maturation of the field of RNA
interference—the sequence-specific gene silencing mediated by small double-stranded …
interference—the sequence-specific gene silencing mediated by small double-stranded …
Efficient gene transfer to the central nervous system by single-stranded Anc80L65
E Hudry, E Andres-Mateos, EP Lerner, A Volak… - … Therapy Methods & …, 2018 - cell.com
Adeno-associated viral vectors (AAVs) have demonstrated potential in applications for
neurologic disorders, and the discovery that some AAVs can cross the blood-brain barrier …
neurologic disorders, and the discovery that some AAVs can cross the blood-brain barrier …
Myc: maestro of microRNAs
TV Bui, JT Mendell - Genes & cancer, 2010 - journals.sagepub.com
Hyperactivity of the Myc oncogenic transcription factor dramatically reprograms gene
expression to facilitate cellular proliferation and tumorigenesis. To elicit these effects, Myc …
expression to facilitate cellular proliferation and tumorigenesis. To elicit these effects, Myc …
Adeno-associated viral vectors and their redirection to cell-type specific receptors
S Michelfelder, M Trepel - Advances in genetics, 2009 - Elsevier
Efficient and specific delivery of genes to the cell type of interest is a crucial issue in gene
therapy. Adeno-associated virus (AAV) has gained particular interest as gene vector recently …
therapy. Adeno-associated virus (AAV) has gained particular interest as gene vector recently …
Prodrug cancer gene therapy
C Altaner - Cancer letters, 2008 - Elsevier
There is no effective treatment for late stage and metastatic cancers of colorectal, prostate,
pancreatic, breast, glioblastoma and melanoma cancers. Novel treatment modalities are …
pancreatic, breast, glioblastoma and melanoma cancers. Novel treatment modalities are …